Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
La industria farmacéutica: los desafíos del nuevo siglo
Bradley, Stephen P.; Weber, JamesCaso HBS-704S16Dirección estratégicaProporciona una visión general de las numerosas fuerzas internas y externas que fueron impulsando el cambio en la industria farmacéutica mundial en el año 2003. Estas fuerzas - incluyendo presiones a la baja de los precios, las presiones políticas y sociales, el aumento de los costes de desarrollo, nuevas tecnologías, competidores nuevos y diferentes, la consolidación y las amenazas a sus modelos de negocio básicos - estaban cambiando la forma en...Desde 8,20 €
-
Dogs of the Dow
Baker, Malcolm P.; Hanson, Samuel G.; Weber, JamesCaso HBS-215020-EFinanzasThis case describes the Dogs of the Dow investment strategy, value investing, and using dividend yields as a means to determine intrinsic value. It also describes exchange traded notes and a particular exchange traded note, known as the Dogs of the Dow, which tracks the performance of the 10 highest yielding stocks of the 30 stocks that make up the Dow Jones Industrial Average (DJIA). The case provides share price data, dividend data, and financi...Desde 8,20 €
-
Longbow Capital Partners
Baker, Malcolm P.; Hanson, Samuel G.; Weber, JamesCaso HBS-215026-EFinanzasLongbow Capital Partners is a value-oriented long/short hedge fund focused on stocks in the energy sector. In January 2011, Longbow invested in NiSource, a Fortune 500 company that owns a diverse portfolio of regulated energy businesses. In late 2014, Longbow was deciding whether or not to maintain its position in NiSource. To make this decision, students must perform a discounted dividend analysis to determine the fundamental value of NiSource's...Desde 8,20 €
-
Pfizer's Centers for Therapeutic Innovation (CTI)
Pisano, Gary P.; Weber, James; Szydlowski, KaitlynCaso HBS-615024-EServicios y operacionesIn 2010, Pfizer established four small research units in New York, Boston, San Francisco, and San Diego located close to several premier Academic Medical Centers (AMCs), or hospitals with adjoining medical schools. The goal of these units was to redesign collaboration with Pfizer and academic medical researchers with the purpose of developing new, innovative drugs candidates for testing in patients. Project teams consisted of Pfizer scientists an...Desde 8,20 €